On the influenza vaccination policy through mathematical modeling

被引:4
|
作者
Ho, Bin-Shenq [1 ,2 ]
Chao, Kun-Mao [1 ,3 ]
机构
[1] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Family Med, Taipei, Taiwan
[3] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei, Taiwan
关键词
Influenza; Vaccination; Timing; Transmission; Modeling; COST-EFFECTIVENESS; EFFICACY; METAANALYSIS; CHALLENGE; RESPONSES; CHILDREN; VACCINES; EUROPE; IMPACT; ADULTS;
D O I
10.1016/j.ijid.2020.06.043
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Aimed at mitigating influenza transmission, this study assessed the timing of the vaccination program and took vaccine capacity, strain mismatch and priority group into consideration. Methods: An age-structured dynamic transmission model was fitted to the laboratory data of the national influenza surveillance system to reconstruct a baseline scenario with which the vaccination scenarios of interest could be compared. Outcome measures were defined as the impacts on the seasonal epidemic: decompression of the epidemic peak, reduction of the epidemic burden and change of the epidemic peak time. Results: It was found that vaccine capacity building, although indispensable, could not guarantee substantial impact on the seasonal influenza epidemic. Vaccine mismatch might greatly offset vaccine capacity building. Notably, advance vaccine distribution could compensate for some vaccine underperformance. In the case of a well-matched vaccine, advance vaccine distribution could even exploit its utility. Conclusions: This study indicated that timely vaccine distribution should be put high on the agenda of seasonal influenza control policies. It provided a tangible platform for the policymakers to evaluate health policy impacts and to enhance risk communication with the public through mathematical modeling. (C) 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
引用
收藏
页码:71 / 79
页数:9
相关论文
共 50 条
  • [21] Real-world effectiveness of influenza vaccination in preventing influenza and influenza-like illness in children
    Rigamonti, Vera
    Torri, Vittorio
    Morris, Shaun K.
    Ieva, Francesca
    Giaquinto, Carlo
    Dona, Daniele
    Di Chiara, Costanza
    Cantarutti, Anna
    VACCINE, 2025, 53
  • [22] INFLUENZA IN THE EMERGENCY DEPARTMENT: VACCINATION, DIAGNOSIS, AND TREATMENT: CLINICAL PRACTICE PAPER APPROVED BY AMERICAN ACADEMY OF EMERGENCY MEDICINE CLINICAL GUIDELINES COMMITTEE
    Abraham, Michael K.
    Perkins, Jack
    Vilke, Gary M.
    Coyne, Christopher J.
    JOURNAL OF EMERGENCY MEDICINE, 2016, 50 (03) : 536 - 542
  • [23] Predictors of influenza vaccination in the US among children 9-13 years of age
    Imburgia, Teresa M.
    Hendrix, Kristin S.
    Donahue, Kelly L.
    Sturm, Lynne A.
    Zimet, Gregory D.
    VACCINE, 2017, 35 (18) : 2338 - 2342
  • [24] Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach
    Brogan, Anita J.
    Talbird, Sandra E.
    Davis, Ashley E.
    Thommes, Edward W.
    Meier, Genevieve
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (03) : 533 - 542
  • [25] Effects of Influenza Vaccination in the United States During the 2018-2019 Influenza Season
    Chung, Jessie R.
    Rolfes, Melissa A.
    Flannery, Brendan
    Prasad, Pragati
    O'Halloran, Alissa
    Garg, Shikha
    Fry, Alicia M.
    Singleton, James A.
    Patel, Manish
    Reed, Carrie
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (08) : E368 - E376
  • [26] Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011
    Kostova, Deliana
    Reed, Carrie
    Finelli, Lyn
    Cheng, Po-Yung
    Gargiullo, Paul M.
    Shay, David K.
    Singleton, James A.
    Meltzer, Martin I.
    Lu, Peng-Jun
    Bresee, Joseph S.
    PLOS ONE, 2013, 8 (06):
  • [27] Effects of Influenza Vaccination in the United States During the 2017-2018 Influenza Season
    Rolfes, Melissa A.
    Flannery, Brendan
    Chung, Jessie R.
    O'Halloran, Alissa
    Garg, Shikha
    Belongia, Edward A.
    Gaglani, Manjusha
    Zimmerman, Richard K.
    Jackson, Michael L.
    Monto, Arnold S.
    Alden, Nisha B.
    Anderson, Evan
    Bennett, Nancy M.
    Billing, Laurie
    Eckel, Seth
    Kirley, Pam Daily
    Lynfield, Ruth
    Monroe, Maya L.
    Spencer, Melanie
    Spina, Nancy
    Talbot, H. Keipp
    Thomas, Ann
    Torres, Salina M.
    Yousey-Hindes, Kimberly
    Singleton, James A.
    Patel, Manish
    Reed, Carrie
    Fry, Alicia M.
    McLean, Huong Q.
    King, Jennifer P.
    Nowalk, Mary Patricia
    Balasubramani, G. K.
    Bear, Todd M.
    Hickey, Robert
    Williams, John V.
    Reis, Evelyn C.
    Moehling, Krissy K.
    Eng, Heather
    Jackson, Lisa A.
    Smith, Michael
    Raiyani, Chandni
    Clipper, Lydia
    Murthy, Kempapura
    Chen, Wencong
    Reis, Michael
    Petrie, Joshua G.
    Malosh, Ryan E.
    McSpadden, E. J.
    Segaloff, Hannah E.
    Cheng, Caroline K.
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (11) : 1845 - 1853
  • [28] Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands
    de Boer, Pieter T.
    Nagy, Lisa
    Dolk, Franklin C. K.
    Wilschut, Jan C.
    Pitman, Richard
    Postma, Maarten J.
    VALUE IN HEALTH, 2021, 24 (01) : 19 - 31
  • [29] Barriers to influenza vaccination among different populations in Shanghai
    Yan, Sijin
    Wang, Yuanping
    Zhu, Weiping
    Zhang, Li
    Gu, Huozheng
    Liu, Dan
    Zhu, Aiqin
    Xu, Hongmei
    Hao, Lipeng
    Ye, Chuchu
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (05) : 1403 - 1411
  • [30] Vaccination against influenza in pregnant women - safety and effectiveness
    Nitsch-Osuch, Aneta
    Wozniak, Kosek Agnieszka
    Brydak, Lidia Bernadeta
    GINEKOLOGIA POLSKA, 2013, 84 (01) : 56 - 61